Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway
Open Access
- 3 April 2007
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (14) , 5771-5776
- https://doi.org/10.1073/pnas.0606514104
Abstract
A multidisciplinary method combining transcriptional data, specificity profiling, and biological characterization of an enzyme may be used to predict novel substrates. By integrating protease substrate profiling with microarray gene coexpression data from nearly 2,000 human normal and cancerous tissue samples, three fundamental components of a protease-activated signaling pathway were identified. We find that MT-SP1 mediates extracellular signaling by regulating the local activation of the prometastatic growth factor MSP-1. We demonstrate MT-SP1 expression in peritoneal macrophages, and biochemical methods confirm the ability of MT-SP1 to cleave and activate pro-MSP-1in vitroand in a cellular context. MT-SP1 induced the ability of MSP-1 to inhibit nitric oxide production in bone marrow macrophages. Addition of HAI-1 or an MT-SP1-specific antibody inhibitor blocked the proteolytic activation of MSP-1 at the cell surface of peritoneal macrophages. Taken together, our work indicates that MT-SP1 is sufficient for MSP-1 activation and that MT-SP1, MSP-1, and the previously shown MSP-1 tyrosine kinase receptor RON are required for peritoneal macrophage activation. This work shows that this triad of growth factor, growth factor activator protease, and growth factor receptor is a protease-activated signaling pathway. Individually, MT-SP1 and RON overexpression have been implicated in cancer progression and metastasis. Transcriptional coexpression of these genes suggests that this signaling pathway may be involved in several human cancers.Keywords
This publication has 40 references indexed in Scilit:
- Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformationGenes & Development, 2005
- CVS‐3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenograftsThe Prostate, 2004
- Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potentialOncogene, 2003
- Inflammation and cancerNature, 2002
- Multiple pulmonary adenomas in the lung of transgenic mice overexpressing the RON receptor tyrosine kinaseCarcinogenesis: Integrative Cancer Research, 2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- α1-Antichymotrypsin Is the Human Plasma Inhibitor of Macrophage Ectoenzymes That Cleave Pro-macrophage Stimulating ProteinPublished by Elsevier ,2001
- Macrophage Stimulating Protein (MSP) Binds to Its Receptor via the MSP β ChainJournal of Biological Chemistry, 1997
- Macrophage-Stimulating Protein Induces Proliferation and Migration of Murine KeratinocytesExperimental Cell Research, 1996
- Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases.Journal of Clinical Investigation, 1996